Intravenous injectable metformin-Cu(ii)-EGCG coordination polymer nanoparticles for electrothermally enhanced dual-drug synergistic tumor therapy

of nanoparticles), coupled with a minimal tumor recurrence rate of only 18.75% over a 60-day observation period. These findings indicate the promising prospects of these nanoparticles in tumor treatment.